<DOC>
	<DOCNO>NCT01651572</DOCNO>
	<brief_summary>The purpose study determine incidence post-operative residual curarization patient determine Cisatracurium Rocuronium behave differently term residual curarization .</brief_summary>
	<brief_title>Comparison Between Cisatracurium Rocuronium Terms Recovery Muscular Strength Postoperative Phase After Surgery General Anaesthesia</brief_title>
	<detailed_description />
	<mesh_term>Delayed Emergence Anesthesia</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>general anaesthesia need use neuromuscularblocking agent awaken extubation patient operate room permanence PACU least 60 minute age 1880 surgical operation last least 1 hour ASA class IIII possibility apply TOFmonitoring thumbacceleromyography woman childbearing age use contraceptive woman childbearing age use contraceptive subject unable give valid consent patient emergency situation patient awaken extubated operating room age 80 year 18 year surgical operation last less hour ASA class IV impossibility apply and/or perform TOFmonitoring neuromuscular disease intake therapy interfere neuromuscular function patient contraindication either study drug pregnant woman woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Postoperative residual curarization</keyword>
	<keyword>Residual neuromuscular block</keyword>
	<keyword>Complications</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Neuromuscular function</keyword>
	<keyword>Neuromuscular block</keyword>
</DOC>